Haemonetics Corporation (NYSE:HAE - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven analysts that are covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one h